MAY 26, 2021 10:00 AM CST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

How Busulfan testing improved the management of Bone Marrow Transplant Patients

Sponsored by: Waters Corporation
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Lead Medical Technologist
    Biography

      I earned a Master Degree in Clinical Biochemistry in 1999 at University of Havana. I got Medical Technologist Licenses in Florida in 2003. I worked as a Technical Supervisor in TDM Lab, University of Miami from 2008 until 2017. From 2017 to 2019, I worked in Quality Assurance, Pathology Department at University of Miami. In 2019, I joined to Baptist Hospital of Miami as Lead Medical Technologist of Chemistry Department to implement and validate LC-MSMS procedures as part of the MCI/BMT Project. 


    Abstract

    Date:  May 26, 2021

    Time: 7:30am (IST), 10:00am (CST), 12pm (AEST)

     

    Therapeutic drug monitoring (TDM) of Busulfan is essential for management of Bone Marrow Transplant (BMT) patients, by optimizing dose, supporting compliance, and minimizing toxicity. Busulfan is a chemotherapeutic agent used as a component in a myeloablative preconditioning regimen before hematological stem cell transplantation. A liquid chromatography-tandem mass spectrometry method for rapid and accurate quantification of Busulfan in plasma was developed and validated in the Department of Chemistry at Baptist Hospital of Miami. The TDM and timely plasma concentration reporting of Busulfan would provide an improvement in the quality-of-care for BMT patients. 

     

    Learning Objectives

    • Identify our purpose to measure Busulfan in BMT patients’ samples.
    • Describe a clinical method to measure Busulfan in plasma by LC-MS/MS.
    • Describe the validation results of the method to measure Busulfan in plasma by LC-MS/MS.

     

     

    Webinars will be available for unlimited on-demand viewing after live event.


    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 19, 2020 8:00 AM GMT
    C.E. CREDITS
    NOV 19, 2020 8:00 AM GMT
    Date: November 19, 2020 Time: 12:00am (PDT), 9:00am (CET), 4:00pm (SGT) We present split-FISH, a multiplexed fluorescence in situ hybridization method that leverages a split-probe design to...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    Loading Comments...
    Show Resources
    Event Countdown
    • 0 Days
    • 0 Hours
    • 0 Minutes
    • 0 Seconds
    Attendees
    • See more